Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Teva Expects 180-Day Generic Exclusivity On Three Pravachol Doses
May 03 2005
•
By
Sue Sutter
More from Archive
More from Pink Sheet